|
Speciality, n (%)
|
|
Oncologist
|
5 (33)
|
1 (7)
|
3 (20)
|
0 (0)
|
0 (0)
|
9 (12)
|
|
Haematologist
|
5 (33)
|
2 (13)
|
7 (47)
|
8 (53)
|
8 (53)
|
30 (40)
|
|
Haemato-oncologist
|
5 (33)
|
12 (80)
|
5 (33)
|
7 (47)
|
7 (47)
|
36 (48)
|
|
Location, n (%)
|
|
University hospital
|
7 (47)
|
10 (67)
|
7 (47)
|
13 (86)
|
11 (73)
|
48 (64)
|
|
Cancer hospital/specialist centre
|
6 (40)
|
4 (27)
|
5 (33)
|
0 (0)
|
2 (13)
|
17 (23)
|
|
Community/urban/general hospital
|
2 (13)
|
1 (7)
|
3 (20)
|
2 (13)
|
2 (13)
|
10 (13)
|
|
Experience, years
|
|
Years treating adults with ALL, median (range)
|
15 (7–29)
|
12 (8–18)
|
10 (6–30)
|
16 (9–34)
|
12 (17–20)
|
N/A
|
|
Caseloada of ALL subtypes from 12 months before the survey, n
|
|
ALL, median (range)
|
30 (3–200)
|
20 (6–100)
|
30 (5–100)
|
20 (3–230)
|
24 (4–200)
|
N/A
|
|
R/R Ph(–) B-precursor ALL, median (range)
|
8 (1–75)
|
3 (1–21)
|
5 (1–50)
|
4 (0–55)
|
4 (1–50)
|
N/A
|
